Valneva SE VALN
5.51 USD -0.13 (-2.30%)
At closeNov 9, 2026, 4:29 AM EST
5.88 +0.37 +6.72%
Pre-market · Nov 9, 4:29 AM ET
5.50 Day range 5.64
4.75 52-week range 12.18
- YTD
- -37.53%
- 1 year
- -36.81%
News
globenewswire.com Valneva Announces Positive Phase 2 Results for Tetravalent Shigella Vaccine Candidate S4V2 Data from infant immunogenicity and safety trial, and controlled human infection model (CHIM) trial, demonstrate favorable safety profile with encouraging immunogenicity and efficacy signals
globenewswire.com Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026 Lyon (France), November 4, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report its nine-month 2026 financial results on Tuesday,…
benzinga.com Full Transcript: Valneva Q2 2026 Earnings Call Valneva (NASDAQ:VALN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For…